These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 29531764)

  • 1. Rationale and design of the ranolazine PH-RV study: a multicentred randomised and placebo-controlled study of ranolazine to improve RV function in patients with non-group 2 pulmonary hypertension.
    Han Y; Forfia PR; Vaidya A; Mazurek JA; Park MH; Ramani G; Chan SY; Waxman AB
    Open Heart; 2018; 5(1):e000736. PubMed ID: 29531764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ranolazine Improves Right Ventricular Function in Patients With Precapillary Pulmonary Hypertension: Results From a Double-Blind, Randomized, Placebo-Controlled Trial.
    Han Y; Forfia P; Vaidya A; Mazurek JA; Park MH; Ramani G; Chan SY; Waxman AB
    J Card Fail; 2021 Feb; 27(2):253-257. PubMed ID: 33223140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of ranolazine on exercise capacity, right ventricular indices, and hemodynamic characteristics in pulmonary arterial hypertension: a pilot study.
    Khan SS; Cuttica MJ; Beussink-Nelson L; Kozyleva A; Sanchez C; Mkrdichian H; Selvaraj S; Dematte JE; Lee DC; Shah SJ
    Pulm Circ; 2015 Sep; 5(3):547-56. PubMed ID: 26401256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-dimensional modeling of the right ventricle from two-dimensional transthoracic echocardiographic images: utility of knowledge-based reconstruction in pulmonary arterial hypertension.
    Bhave NM; Patel AR; Weinert L; Yamat M; Freed BH; Mor-Avi V; Gomberg-Maitland M; Lang RM
    J Am Soc Echocardiogr; 2013 Aug; 26(8):860-7. PubMed ID: 23768691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Study of the Efficacy and Safety of Aerobic Exercise Training in Pulmonary Arterial Hypertension (the Saturday Study): Protocol for a Prospective, Randomized, and Controlled Trial.
    Jiang R; Wang L; Yuan P; Zhao QH; Gong SG; He J; Qiu HL; Luo CJ; Zhang R; Shen T; Zhan MY; Jiang YM; Chen FD; Liu JM; Shen YQ
    Front Med (Lausanne); 2022; 9():835272. PubMed ID: 35449803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Association between echocardiography derived right ventricular function parameters with cardiac magnetic resonance derived right ventricular ejection fraction and 6-minute walk distance in pulmonary hypertension patients].
    Wang Z; Yang Z; Wan Z; Yu T; Jia L; Du X; Huang C
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Sep; 42(9):748-52. PubMed ID: 25511095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and prognostic value of right ventricular strain in patients with pulmonary arterial hypertension and relatively preserved functional capacity studied with echocardiography and magnetic resonance.
    da Costa Junior AA; Ota-Arakaki JS; Ramos RP; Uellendahl M; Mancuso FJ; Gil MA; Fischer CH; Moises VA; de Camargo Carvalho AC; Campos O
    Int J Cardiovasc Imaging; 2017 Jan; 33(1):39-46. PubMed ID: 27566191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Right ventricular strain in pulmonary arterial hypertension: a 2D echocardiography and cardiac magnetic resonance study.
    Freed BH; Tsang W; Bhave NM; Patel AR; Weinert L; Yamat M; Vicedo BM; Dill K; Mor-Avi V; Gomberg-Maitland M; Lang RM
    Echocardiography; 2015 Feb; 32(2):257-63. PubMed ID: 24975738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diuretic versus placebo in normotensive acute pulmonary embolism with right ventricular enlargement and injury: a double-blind randomised placebo controlled study. Protocol of the DiPER study.
    Gallet R; Meyer G; Ternacle J; Biendel C; Brunet A; Meneveau N; Rosario R; Couturaud F; Sebbane M; Lamblin N; Bouvaist H; Coste P; Maitre B; Bastuji-Garin S; Dubois-Rande JL; Lim P
    BMJ Open; 2015 May; 5(5):e007466. PubMed ID: 26002690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The predictive capabilities of a novel cardiovascular magnetic resonance derived marker of cardiopulmonary reserve on established prognostic surrogate markers in patients with pulmonary vascular disease: results of a longitudinal pilot study.
    Baillie TJ; Sidharta S; Steele PM; Worthley SG; Willoughby S; Teo K; Sanders P; Nicholls SJ; Worthley MI
    J Cardiovasc Magn Reson; 2017 Jan; 19(1):3. PubMed ID: 28065166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CMR-based heart deformation analysis for quantification of hemodynamics and right ventricular dysfunction in patients with CTEPH.
    Tao X; Liu M; Liu W; Xie W; Wan J; Zhai Z; Wang C
    Clin Respir J; 2020 Mar; 14(3):277-284. PubMed ID: 31814279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tricuspid regurgitation duration correlates with cardiovascular magnetic resonance-derived right ventricular ejection fraction and predict prognosis in patients with pulmonary arterial hypertension.
    Cho IJ; Oh J; Chang HJ; Park J; Kang KW; Kim YJ; Choi BW; Shin S; Shim CY; Hong GR; Ha JW; Chung N
    Eur Heart J Cardiovasc Imaging; 2014 Jan; 15(1):18-23. PubMed ID: 23704751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between right ventricular T
    Jellis CL; Yingchoncharoen T; Gai N; Kusunose K; Popović ZB; Flamm S; Kwon D
    Int J Cardiovasc Imaging; 2018 Jan; 34(1):55-65. PubMed ID: 28357724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of pulmonary vasodilating agents on right ventricular parameters in severe group 3 pulmonary hypertension: a pilot study.
    Sato T; Tsujino I; Sugimoto A; Nakaya T; Watanabe T; Ohira H; Suzuki M; Konno S; Oyama-Manabe N; Nishimura M
    Pulm Circ; 2016 Dec; 6(4):524-531. PubMed ID: 28090294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of right ventricular ejection/filling parameters in IPAH using cardiac magnetic resonance: A prospective pilot study.
    Li W; Yang T; Zhang Y; Gu Q; Liu ZH; Ni XH; Luo Q; Xiong CM; He JG
    Respirology; 2017 Jan; 22(1):172-178. PubMed ID: 27442028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Losartan on Right Ventricular Dysfunction: Results From the Double-Blind, Randomized REDEFINE Trial (Right Ventricular Dysfunction in Tetralogy of Fallot: Inhibition of the Renin-Angiotensin-Aldosterone System) in Adults With Repaired Tetralogy of Fallot.
    Bokma JP; Winter MM; van Dijk AP; Vliegen HW; van Melle JP; Meijboom FJ; Post MC; Berbee JK; Boekholdt SM; Groenink M; Zwinderman AH; Mulder BJM; Bouma BJ
    Circulation; 2018 Apr; 137(14):1463-1471. PubMed ID: 29222139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment goals of pulmonary hypertension.
    McLaughlin VV; Gaine SP; Howard LS; Leuchte HH; Mathier MA; Mehta S; Palazzini M; Park MH; Tapson VF; Sitbon O
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D73-81. PubMed ID: 24355644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RAnoLazIne for the treatment of diastolic heart failure in patients with preserved ejection fraction: the RALI-DHF proof-of-concept study.
    Maier LS; Layug B; Karwatowska-Prokopczuk E; Belardinelli L; Lee S; Sander J; Lang C; Wachter R; Edelmann F; Hasenfuss G; Jacobshagen C
    JACC Heart Fail; 2013 Apr; 1(2):115-22. PubMed ID: 24621836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Right ventricular function parameters in pulmonary hypertension: echocardiography vs. cardiac magnetic resonance.
    Evaldsson AW; Lindholm A; Jumatate R; Ingvarsson A; Smith GJ; Waktare J; Rådegran G; Roijer A; Meurling C; Ostenfeld E
    BMC Cardiovasc Disord; 2020 Jun; 20(1):259. PubMed ID: 32487063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential Right and Left Ventricular Assessment in Posttetralogy of Fallot Patients with Significant Pulmonary Regurgitation.
    Wijesekera VA; Raju R; Precious B; Berger AJ; Kiess MC; Leipsic JA; Grewal J
    Congenit Heart Dis; 2016 Dec; 11(6):606-614. PubMed ID: 27225732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.